Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Clinical Infectious Diseases ; (6): 176-184, 2022.
Artigo em Chinês | WPRIM | ID: wpr-957258

RESUMO

Since the end of 2019, the COVID-19 caused by 2019-nCoV has emerged and the pandemic ravaged the world, which seriously threatens global public health security and economic development. 2019-nCoV vaccine is an effective weapon to combat the viral infection, however, studies have shown that vaccine-induced immune protection decreases over time, coupled with some novel and immune escape variants continual emerging. Therefore, it is urgent to complete booster immunization to improve protection. At present, 2019-nCoV vaccines based on a variety of technical platforms have been approved and available in China. Therefore, we developed this sequential vaccination strategy guide to provide documentation guidance for the prevention and control of the epidemic caused by 2019-nCoV and its variant strains.

2.
Gac. méd. Méx ; 157(supl.4): S1-S12, feb. 2021.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1375516

RESUMO

Resumen La esquizofrenia es una enfermedad compleja que actualmente no tiene cura. Existen, sin embargo, numerosas terapias que, solas o en combinación, son eficaces para tratar los síntomas de la enfermedad y mantenerla bajo control. La elección del tratamiento debe ser siempre individualizada, y basarse en la presentación clínica de la enfermedad, el estado general del paciente y la eficacia del fármaco, si bien hay que considerar también el costo y el acceso a servicios y al fármaco, que en México tiene algunas limitaciones. Un panel de 12 expertos mexicanos se reunió de forma virtual para revisar los últimos datos publicados y establecer unas recomendaciones de tratamiento en México, basadas en la evidencia, que garanticen una atención médica integral, homogénea, eficiente y con calidad.


Abstract Schizophrenia is a complex illness that currently has no cure. There are, however, numerous therapies that, alone or in combination, are effective in treating the symptoms of the disease and keeping it under control. The choice of treatment must always be individualized, and based on the clinical presentation of the disease, the general condition of the patient and the efficacy of the drug, although the cost and access to services and to the drug must also be considered, as in Mexico it has some limitations. A panel of 12 Mexican experts met virtually to review the latest published data and establish evidence-based treatment recommendations in Mexico that guarantee comprehensive, homogeneous, efficient, and quality medical care.

3.
Chinese Journal of Surgery ; (12): 641-649, 2019.
Artigo em Chinês | WPRIM | ID: wpr-797578

RESUMO

Minimally invasive esophagectomy for the surgical treatment of esophageal cancer has gradually been recognized and applied. With the application of robot-assisted technology in esophageal surgery, robot-assisted esophagectomy has been carried out in large domestic centers, and its feasibility and safety have been recognized by some domestic experts. In view of no advice or guidelines about robot-assisted esophagectomy has been written before, Committee of Esophageal Cancer in China Anticancer Association organized relevant domestic experts to establish this expert recommendation for standardization of robot-assisted esophagectomy, aiming at helping surgeons perform this complex procedure safely.

4.
Chinese Journal of Surgery ; (12): 561-567, 2019.
Artigo em Chinês | WPRIM | ID: wpr-810802

RESUMO

Radical resection is the only curable treatment for perihilar cholangiocarcinoma.With the continuous renewal of laparoscopic instruments and the continuous improvement of technology, laparoscopic radical resection of perihilar cholangiocarcinoma has been gradually carried out in China, and its feasibility and safety have been recognized by some domestic peers. In order to standardize clinical diagnosis and treatment behavior, ensure patients receive safe and standardized treatment and improve prognosis, so that the operation can be standardized application and development. Based on the principles of treatment of perihilar cholangiocarcinoma and the corresponding technical norms of laparoscopic operation, the Expert Group on Operational Norms of Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma and Editorial Board of Chinese Journal of Surgery have organized relevant domestic experts to formulate expert recommendations for laparoscopic radical resection of perihilar cholangiocarcinoma, so as to facilitate clinical practice and standardized application.

5.
Chinese Journal of Surgery ; (12): 561-567, 2019.
Artigo em Chinês | WPRIM | ID: wpr-772322

RESUMO

Radical resection is the only curable treatment for perihilar cholangiocarcinoma.With the continuous renewal of laparoscopic instruments and the continuous improvement of technology, laparoscopic radical resection of perihilar cholangiocarcinoma has been gradually carried out in China, and its feasibility and safety have been recognized by some domestic peers. In order to standardize clinical diagnosis and treatment behavior, ensure patients receive safe and standardized treatment and improve prognosis, so that the operation can be standardized application and development. Based on the principles of treatment of perihilar cholangiocarcinoma and the corresponding technical norms of laparoscopic operation, the Expert Group on Operational Norms of Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma and Editorial Board of Chinese Journal of Surgery have organized relevant domestic experts to formulate expert recommendations for laparoscopic radical resection of perihilar cholangiocarcinoma, so as to facilitate clinical practice and standardized application.


Assuntos
Humanos , Neoplasias dos Ductos Biliares , Cirurgia Geral , Colangiocarcinoma , Cirurgia Geral , Hepatectomia , Métodos , Padrões de Referência , Tumor de Klatskin , Cirurgia Geral , Laparoscopia , Padrões de Referência
6.
Chinese Journal of Surgery ; (12): 641-649, 2019.
Artigo em Chinês | WPRIM | ID: wpr-772321

RESUMO

Minimally invasive esophagectomy for the surgical treatment of esophageal cancer has gradually been recognized and applied. With the application of robot-assisted technology in esophageal surgery, robot-assisted esophagectomy has been carried out in large domestic centers, and its feasibility and safety have been recognized by some domestic experts. In view of no advice or guidelines about robot-assisted esophagectomy has been written before, Committee of Esophageal Cancer in China Anticancer Association organized relevant domestic experts to establish this expert recommendation for standardization of robot-assisted esophagectomy, aiming at helping surgeons perform this complex procedure safely.


Assuntos
Humanos , Neoplasias Esofágicas , Cirurgia Geral , Esofagectomia , Métodos , Procedimentos Cirúrgicos Minimamente Invasivos , Guias de Prática Clínica como Assunto , Procedimentos Cirúrgicos Robóticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA